# US 8,278,355 B2 · Isovaline for treatment of pain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,355 B2
- Document ID: US8278355B2
- Status: Granted
- Kind: B2
- Application number: 12/441,054
- Filed: 2007-09-12
- Published: 2010-06-03
- Granted: 2012-10-02
- Earliest claimed: 2006-09-12
- Assignees: Therexcell Pharma Inc.
- Inventors: Ernest Puil; Bernard Ansel MacLeod; Thomas Michael Stokes; Wei Liu
- Web page: https://patentgrep.com/patent/US8278355B2

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61P 25/02: for peripheral neuropathies
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides for the use of isovaline or a pharmaceutically acceptable salt thereof for the treatment of Pain in a mammalian subject in some preferred embodiments, the invention provides for the treatment of acute and chronic Pain syndromes where other drug therapies have limited efficacy or unacceptable toxicity in said subject.

## Claims

### Claim 1

A method of treating a pain in a mammalian subject in need thereof, comprising administering to the subject an amount of an isovaline or a pharmaceutically acceptable salt thereof wherein the isovaline is the sole active agent.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the isovaline is R isovaline.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the isovaline is S isovaline.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the isovaline comprises R and S isovaline.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the subject is a human.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the isovaline is administered parenterally.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the isovaline is administered intrathecally.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the pain is a neuropathic pain.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the pain is not associated with a diabetic neuropathy.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the pain is not caused by an organic pathology.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the effective amount of isovaline has an analgesic effect in the subject but is not effective to treat pain caused by an organic pathology in the subject.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the effective amount of isovaline has an analgesic effect in the subject but is not effective to inhibit dipeptidyl peptidase IV in the subject.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the pain results from one or more causes selected from the group consisting of: a peripheral neuropathy, a central neuropathy, a traumatic abnormality, a cerebral vascular accident, postoperative pain, dental pain, direct trauma, infection, HIV infection, small pox infection, herpes infection, toxic exposure, exposure to arsenic, exposure to lead, cancer, invasive cancer, congenital defect, phantom limb pain, encephalitis, rheumatoid arthritis, fibromyalgias, spinal root lesions, spinal root impingment, back pain, multiple sclerosis, chronic pain, fibrous tissue pain, muscle pain, tendon pain, ligament pain, pain associated with diarrhea, irritable bowel syndrome, abdominal pain, chronic fatigue syndrome, and spasms.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the subject has been diagnosed as being refractory to effective treatment with at least one analgesic other than isovaline.
